Stockscreener 앱 받기
1.51
7.93%
-0.13
시간 외 거래:
1.51
전일 마감가:
$1.64
열려 있는:
$1.64
하루 거래량:
324.46K
Relative Volume:
0.97
시가총액:
$70.53M
수익:
$13.18M
순이익/손실:
$-9.65M
주가수익비율:
-7.9307
EPS:
-0.1904
순현금흐름:
$-8.58M
1주 성능:
-4.43%
1개월 성능:
-10.12%
6개월 성능:
-43.45%
1년 성능:
+0.00%
1일 변동 폭
$1.46
$1.66
1주일 범위
$1.46
$1.69
52주 변동 폭
$0.99
$2.99
Mindwalk Holdings Corp Stock (HYFT) Company Profile
Compare HYFT vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HYFT
Mindwalk Holdings Corp
|
1.51 | 76.61M | 13.18M | -9.65M | -8.58M | -0.1904 |
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.94 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.59 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Mindwalk Holdings Corp Stock (HYFT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-12-02 | 개시 | H.C. Wainwright | Buy |
| 2021-10-25 | 개시 | The Benchmark Company | Buy |
Mindwalk Holdings Corp 주식(HYFT)의 최신 뉴스
MindWalk Holdings Added to Russell 3000E Index, Boosting Bio-Native AI Visibility - TipRanks
Russell 3000E addition expands MindWalk (NASDAQ: HYFT) index access - Stock Titan
MindWalk added to Russell 3000E Index effective June 26 - Investing.com
As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models - The Globe and Mail
MindWalk Holdings Corp. (NASDAQ: HYFT) Added to the Russell 3000E Index, Expanding Institutional Investment Opportunity - Business Wire
Top MindWalk (HYFT) Competitors 2026 - MarketBeat
H.C. Wainwright reiterates Buy on MindWalk stock, $5 target By Investing.com - Investing.com South Africa
MindWalk Holdings Corp. Financial Disclosures & Filings - TradingView
MindWalk Holdings Corp. (HYFT) Files Patent for Advanced AI in L - GuruFocus
As AI Models Become Commodities, One Bio-Native AI Company Just Moved to Patent the Thing That Actually Compounds: the Data - Investing News Network
MindWalk Files European Patent for High-Dimensional Biological Data Layer Powering AI Drug Discovery - TipRanks
MindWalk (NASDAQ: HYFT) seeks EU patent on AI-driven biological data layer - Stock Titan
MindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery - Yahoo Finance
MindWalk Holdings Corp.(NasdaqCM:HYFT) added to Russell Microcap Value Benchmark Index - marketscreener.com
MindWalk Holdings Corp.(NasdaqCM: HYFT) added to Russell 3000E Index - marketscreener.com
MindWalk Holdings Corp.(NasdaqCM: HYFT) added to Russell Microcap Index - marketscreener.com
MindWalk Holdings Corp.(NasdaqCM: HYFT) added to Russell 3000E Growth Benchmark - marketscreener.com
MindWalk Holdings Corp.(NasdaqCM:HYFT) added to Russell Microcap Growth Benchmark Index - marketscreener.com
MindWalk Holdings Corp.(NasdaqCM: HYFT) added to Russell 3000E Value Benchmark - marketscreener.com
MindWalk Holdings Corp. Actuals & Estimates (NASDAQ:HYFT) - TradingView
HYFT Forecast — Price Target — Prediction for 2027 - TradingView
TQB0 Forecast — Price Target — Prediction for 2027 - TradingView
MindWalk (HYFT) Earnings Date and Reports 2026 - MarketBeat
Price to earnings forward of MindWalk Holdings Corp. – NASDAQ:HYFT - TradingView
Price to sales forward of MindWalk Holdings Corp. – NASDAQ:HYFT - TradingView
Price to book forward of MindWalk Holdings Corp. – NASDAQ:HYFT - TradingView
This Stock Is A Once-In-A-Lifetime Steal Radio-canada (R6akZrRcrT) - Mshale
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It - marketscreener.com
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It - Benzinga
HYFT News | MINDWALK HOLDINGS CORP (NASDAQ:HYFT) - ChartMill
HYFT Q1 2026 Earnings: Wider-Than-Expected Loss Highlights Ongoing Investment PhaseLow Growth Earnings - newsline.com
MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ - marketscreener.com
MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery - 01net
MindWalk CEO to Join Jones AI Day Panel on Future of AI Drug Discovery - TipRanks
MindWalk (NASDAQ: HYFT) CEO joins Jones AI Day panel on AI drug discovery - Stock Titan
MINDWALK HOLDINGS CORP (HYFT) Stock Chart - ChartMill
HYFT Q1 2026 Earnings: EPS Misses Estimates, Stock Declines 3.01%Positive Surprise Momentum - newsline.com
HYFT Unveils ReefIQ for Enhanced AI Drug Discovery - GuruFocus
MindWalk Holdings Corp. Launches ReefIQ™ for AI-Driven Drug Disc - GuruFocus
MindWalk Holdings Unveils ReefIQ Context Layer to Power AI Drug Discovery - TipRanks
MindWalk (NASDAQ: HYFT) debuts ReefIQ context layer for AI drug discovery - Stock Titan
MindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ™, a Biological Context Layer for AI Drug Discovery - The Joplin Globe
HYFT Q1 2026 Earnings: EPS Falls Short of Estimates as Stock Gains 3.75%EPS Growth Report - newsline.com
HYFT Q1 2026 Earnings: EPS Misses Estimates, Stock Slides Over 9%Earnings Power Value - newsline.com
MindWalk Showcases HYFT® Platform With Pan-Serotype Dengue Preclinical Data - TipRanks
MindWalk (NASDAQ: HYFT) reports HYFT AI preclinical dengue antibodies across all four serotypes - Stock Titan
MindWalk's HYFT Platform Shows Promising Preclinical Dengue Vacc - GuruFocus
MindWalk reports preclinical dengue vaccine data By Investing.com - Investing.com Nigeria
Bio-Native AI therapeutics MindWalk sets March 12 Q3 earnings call - Stock Titan
MindWalk reports preclinical dengue vaccine data - Investing.com
MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypes, Reproduced Across Two Independent Camp - Business Wire
Mindwalk Holdings Corp (HYFT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
2.48%
자본화:
|
볼륨(24시간):